35
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Genetic Studies of Human Lupus in Families

Pages 297-317 | Published online: 10 Jul 2009

References

  • Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am. J. Hum. Genet 1987; 40: 1–14
  • Vyse T. J., Todd J. A. Genetic analysis of autoimmune disease. Cell 1996; 85: 311–318
  • Arnett F. C. The genetics of human lupus. Dubois' Lupus Erythematosus, D. J. Wallace, B. H. Hahn. Williams & Wilkins. 1997; 77
  • Tan F. K., Arnett F. C. The genetics of lupus. Curr. Opin. Rheumatol 1998; 10: 399–408
  • Hochberg M. C. The application of genetic epidemiology to systemic lupus erythematosus. J. Rheumatol 1987; 14: 867–869
  • Lawrence J. S., Martins C. L., Drake G. L. A family survey of lupus erythematosus: 1. Heritability. J. Rheumatol 1987; 14: 913–921
  • Deapen D., Escalante A., Weinrib L., Horwitz D., Bachman B., Roy P., BurmanWalker A., Mack T. M. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 311–318
  • Grennan D. M., Parfitt A., Manolios N., Huang Q., Hyland V., Dunckley H., Doran T., Gatenby P., Badcock C. Family and twin studies in systemic lupus erythematosus. Dis. Markers 1997; 13: 93–98
  • Gregersen P. K. Discordance for autoimmunity in monozygotic twins. Are identical twins really identical. Arthritis Rheum 1993; 36: 1185–1192
  • Arnett F. C., Shulman L. E. Studies in familial systemic lupus erythematosus. Medicine 1976; 55: 313–322
  • Arnett F. C., Reichlin M. D. Lupus Hepatitis: An under-recognized disease feature associated with autoantibodies to ribosomal P. Am. J. Med 1995; 99: 465–472
  • Miles S., Isenberg D. A review of serological abnormalities in relatives of SLE patients. Lupus 1993; 2: 145–150
  • Arnett F. C., Hamilton R. G., Reveille J. D., Bias W. B., Harley J. B., Reichlin M. Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjogren's syndrome. Arthritis Rheum 1989; 32: 413–419
  • Miller K. B., Schwartz R. S. Familial abnormalities of suppressor-cell function in systemic lupus erythematosus. N. Engl. J. Med 1979; 301: 803–809
  • Jabs D. A., Arnett F. C., Bias W. B., Beale M. G. Familial abnormalities of lymphocyte function in a large Sjogren's syndrome kindred. J. Rheumatol 1985; 13: 320–326
  • Spencer G., GreenAdams L. E., Hurtubise P., Kravatz G., Hess E. Familial alterations of immunoregulation in systemic lupus erythematosus. J. Rheumatol 1985; 2: 498–503
  • Grondal G., Kristjansdottir H., Gunnlaugsdottir B., Arnason A., Lundberg I., Klareskog L., Steinsson K. Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families. Arthritis Rheum 1999; 42: 1649–1654
  • Sakane T., Murakawa Y., Nhoboru S., Ueda Y., Tsuchida T., Takada S., Yamauchi Y., Tsunematsu T. Familial occurrence of impaired interleukin-2 activity and increased peripheral blood B cells actively secreting immunoglobulins in systemic lupus erythematosus. Am. J. Med 1989; 86: 385–390
  • Sibley J. T., Haug B. L., Lee J. S. Altered metabolism of poly (ADP-ribose) in the peripheral blood lymphocytes of patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1045–1049
  • Haug B. L., Lee J. S., Sibley J. T. Altered poly (ADP-ribose) metabolism in family members of patients with systemic lupus erythematosus. J. Rheumatol 1994; 21: 851–856
  • Lahita R. G., Chiorazzi N., Gifofsky A., Winchester R. J., Kunkel H. G. Familial systemic lupus erythematosus in males. Arthritis Rheum 1983; 26: 39–44
  • Lippman S. M., Arnett F. C., Conley C. L., Ness P. M., Myers D. A., Bias W. B. Genetic factors predisposing to autoimmune diseases. Autoimmune hemolytic anemia, chronic thrombocytopenia purpura, and systemic lupus erythematosus. Am. J. Med 1982; 73: 827–840
  • Amett F. C., Reveille J. D., Wilson R. W., Provost T. T., Bias W. B. Systemic lupus erythematosus: current state of the genetic hypothesis. Semin. Arthritis Rheum 1984; 14: 24–35
  • Bias W. B., Reveille J. D., Beaty T. L.H., Meyers D. A., Arnett F. C. Evidence that autoimmunity in man is a mendelian-dominant trait. Amer. J. Hum. Genet 1986; 39: 584–602
  • Freedman B. I., Wilson C. H., Spray B. J., Tuttle A. B., Olorenshaw I. M., Kammer G. M. Familial clustering of end-stage renal disease in blacks with lupus nephritis. Amer. J. Kidney Dis 1997; 29: 729–732
  • Grumet F. C., Coukell A., Bodmer J. G., Bodmer W. F., Mc Devitt H. O. Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease. N. Engl. J. Med 1971; 285: 193–196
  • Nepom B. S., Nepom G. T. Polyglot and polymorphism. Arthritis & Rheum 1995; 38: 1715–1721
  • The MHC sequencing consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature 1999; 401: 921–923
  • Todd J. A., Acha H., OrbeaBell J. I., Chao N., Fronek Z., Jacob C. O., Mc M., Dermott Sinha A. A., Timmerman L., Steinman L., McDevitt H. O. A molecular basis for MHC class II-associated autoimmunity. Science 1988; 240: 1003–1008
  • Gregersen P. K., Silver J., Winchester R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205–1213
  • Todd J. A., Mijovic C., Fletcher J., Jenkins D., Bradwell A. R., Barnett A. H. Identification of susceptibility loci for insulin-dependent diabetes mellitus by transracial gene mapping. Nature 1989; 338: 587–588
  • Reveille J. D., Bias W. B., Winkelstein J. A., Provost T. T., Dorsch C. A., Arnett F. C. Familial systemic lupus erythematosus: immunogenetic studies in eight families. Medicine (Baltimore) 1983; 62: 21–35
  • Arnett F. C., Bias W. B., Reveille J. D. Genetic studies in Sjogren's syndrome and systemic lupus erythematosus. J. Autoimmunity 1989; 2: 403–413
  • Reveille J. D., Mac M. J., Leod Whittington K., Arnett F. C. Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses. J. Immunol 1991; 146: 3871–3876
  • Arnett F. C., Thiagarajan P., Ahn C., Reveille J. D. Associations of anti-β2-glycoprotein I autoantibodies with HLA class II alleles in three ethnic groups. Arthritis & Rheum 1999; 42: 268–274
  • Arnett F. C., Reveille J. D., Moutsopoulos H. M., Georgescu L., Elkon K. B. Ribosomal P autoantibodies in systemic lupus erythematosus: frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum 1996; 39: 1833–1839
  • Arnett F. C. HLA and autoimmunity in scleroderma (systemic sclerosis). Internal. Rev. Immunol 1995; 12: 107–128
  • Arnett F. C., Reveille J. D. The genetics of lupus erythematosus. Rheum. Dis. Clin. N. Amer 1992; 18: 865–892
  • Kahl L. E., Atkinson J. P. Autoimmune aspects of complement deficiency. Clin. Asp. Autoimmun 1988; 2: 8–20
  • Schur P. H. Complement and systemic lupus erythematosus. Dubois' Lupus Erythematosus, D. R. Wallace, B. H. Hahn. Williams & Wilkins, Baltimore 1997; 245
  • Slingsby J. H., Norsworthy P., Pearce G., Vaishnaw A. K., Issler H., Morley B. J., Walport M. J. Homozygous hereditary Clq deficiency and systemic lupus erythematosus. Arthritis & Rheum 1996; 39: 663–670
  • Carroll M. C., Palsdotin A., Belt K. T., Porter R. R. Deletion of complement C4 and 21-hydroxylase genes in the HLA class III region. EMBO J 1985; 4: 2547–2552
  • Sullivan K. E., Kim N. A., Golman D., Petri M. A. C4A deficiency due to a 2 bp insertion is increased in patients with systemic lupus erythematosus. J. Rheum 1999; 26: 2144–2147
  • Howard P. F., Hochberg M. C., Bias W. B., Arnett F. C., McLean R. H. Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibilities to systemic lupus erythematosus in Caucasians and black Americans. Am. J. Med 1986; 81: 187–193
  • Kemp M. E., Atkinson J. P., Skanes V. M., Levine R. P., Chaplin D. D. Deletion of C4A genes in patients with systemic lupus erythematosus. Arthritis Rheum 1987; 30: 1015–1022
  • Batchelor J. R., Fielder A. H.L., Walport M. J., David J., Lord D. K., Davey N., Dodi L. A., Malasit P., Wanachiwanawin W., Bernstein R., Mackworth Young C., Isenberg D. Family study of the major histocompatibility complex in HLA DR3 negative patients with systemic lupus erythematosus. Clin. Exp. Immunol 1987; 70: 364–371
  • Wilson W. A., Perez M. C. Complete C4B deficiency in Black Americans with systemic lupus erythematosus. J. Rheumatol 1988; 15: 1855–1858
  • Reveille J. D., Moulds J. M., Arnett F. C. Major histocompatibility complex class II and C4 alleles in Mexican Americans with systemic lupus erythematosus. Tissue Antigens 1995; 45: 91–97
  • Sullivan K. E., Petri M. A., Schmeckpeper B. J., Mc Lean R. H., Winkelstein J. A. Prevalence of a mutation causing C2 deficiency in systemic lupus erythematosus. J. Rheumatol 1994; 21: 1128–1133
  • Lipscombe R. J., Sumiya M., Summerfield J. A., Turner M. W. Distinct physiochemical characteristics of human mannose binding protein expressed by individual of differing genotypes. Immunology 1995; 85: 660–667
  • Malhotra U., Wonnald M. R., Rudd P. M., Fischer P. B., Dwek R. A., Sim R. B. Glycosylation changes of IgG associated with rheumatoid arthrits can active complement via mannose-binding protein. Nat. Med 1995; 1: 237–243
  • Senaldi G., Davies E. T., Pearkman M., Veragani D., Lu J., Reid K. B.M. Frequency of mannose-binding protein deficiency in patients with systemic lupus erythematosus. Arthritis & Rheum 1995; 38: 1713–1714
  • Lau Y. L., Lau C. S., Chan S. Y., Karlberg J., Turner M. W. Mannose-binding protein in Chinese patients with systemic lupus erythematosus. Arthritis & Rheum 1996; 39: 706–708
  • Summerfield J. A., Ryder S., Sumiya M., Thursz M., Gorchein A., Monteil M. A., Turner M. W. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995; 345: 886–889
  • Garred P., Madsen H. O., Halberg P., Petersen J., Kronborg G., Svejgaard A., Andersen V., Jacobsen S. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis & Rheum 1999; 42: 2145–2152
  • Reveille J. D., Arnett F. C., Wilson R. W., Bias W. B., LeanMc R. H. Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus. Immunogenet 1985; 21: 299–311
  • Jones J. V., Jones E., Forsyth S. J., Skanes V. M., Reichlin M., Mac J. M., Sween Eastwood S., Carr R. I. Familial systemic lupus erythematosus: evidence for separate loci controlling C4 deficiency and formation of antibodies to DNA, nRNP, Ro and La. J. Rheumatol 1987; 14: 263–267
  • Wilson W. A., Scopelitis E., Michalski J. P., Pierangeli S. S., Silveira L. H., Elston R. C., Harris E. N. Familial anticardiolipin antibodies and C4 deficiency genotypes that coexist with MHC DQB1 risk factors. J. Rheumatol 1995; 22: 227–235
  • Huang D. F., Siminovitch K. A., Liu X. Y., Olee T., Olsen N. J., Berry C., Carson D. A., Chen P. P. Population and family studies of three disease-related polymorphic genes in systemic lupus erythematosus. J. Clin. Invest 1995; 1766–1772
  • Tebib J. G., Alcocer J., VerelaAlarcon-Segovia D., Schur P. H. Association between a T-cell receptor restriction fragment length polymorphism and systemic lupus erythematosus. J. Clin. Invest 1990; 86: 1961–1967
  • Frank M. B., Mc R., Arthur Barley J. B., Fujisaku A. Anti-Ro (SSA) autoantibodies are associated with T-cell receptor beta genes in systemic lupus erythematosus patients. J. Clin. Invest 1990; 85: 33–39
  • Dunckley H., Gatenby P. A., Serjeantson S. W. T-cell receptor and HLA-class II RFLP's in systemic lupus erythematosus. Immunogenet 1988; 27: 392–395
  • Huang Q., Morris D. Dunckley, D. Grennan and N. Manolios, Lack of linkage between antinuclear antibody or clinical features of systemic lupus erythematosus and TCRA/Vb loci in families of subjects with SUE. Lupus 1997; 6: 527–532
  • Reveille J. D., Wilson R. W., Provost T. T., Bias W. B., Arnett F. C. Primary Sjogren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann. Intern. Med 1984; 101: 748–756
  • Olee T., Yang P. M., Siminovitch K. A., Olsen N. J., Hillson J., Wu J., Kozin F., Carson D. A., Chen P. P. Molecular basis of an autoantibody-associated restriction fragment length polymorphism that confers susceptibility to autoimmune diseases. J. Clin. Invest 1991; 88: 193–203
  • Kimberly R. P., Salmon J. E., Edgerg J. Receptors for immunoglobulin G. Arthritis & Rheum 1995; 38: 306–314
  • Rascu A., Repp R., Westerdaal N. A.C., Kalden J. R., van de Winkle J. G.J. Clinical Relevance of FCγ receptor polymorphisms. Ann. N. Y. Acad. Sci 1997; 815: 282–295
  • Salmon J. E., Millard S., Schacter L. A., Arnett F. C., Ginzler E. M., Gourley M. F., Ramsey R., GoldmanPeterson M. G.E., Kimberly R. P. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African-Americans. J. Clin. Invest 1996; 97: 1348–1354
  • Duits A. J., Bootsma H. R., Derksen H. W.M., Spronk P. E., Kater L., Kallenberg C. G.M., Capel P. J.A., Westerdaal N. A.C., Spierenburg G., Gmelig meyling F. H.J., van de winkel J. G.J. Skewed distribution of IgG Fc receptor Ha (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 1995; 39: 1832–1836
  • Wu J., Edberg J. C., Redecha P. B., Bansal V., Guyre P. M., Coleman K., Salmon J. E., Kimberly R. P. A novel polymorphism of Fc gamma RHIa (CD16) alters receptor function and predisposes to autoimmune disease. J. Clin. Invest 1997; 100: 1059–1070
  • Jacob C. O., Fronek Z., Lewis G. D., Koo M., Hansen J. A., McDevitt H. O. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 1990; 87: 1233–1237
  • Komata T., Tsuchiya N., Matsushita M., Hagiwara K., Tokunaga K. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens 1999; 53: 527–533
  • Llorente L., Zou W., Levy Y., Richaud Y., PatinWijdennes J., Alcocer J., VarelaMorel B., FourrierBrouet J. C., Alarcon D., SegoviaGalanaud P., Emilie D. Role of interleukin-10 in the B-lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med 1995; 181: 839–844
  • Llorente L., Richaud Y., PatinCouderc J., Alarcon D., SegoviaRuiz R., SotoAlcocer N., CasteillejosAlcocer J., VarelaGranados J., Bahena S., Galanaud P., Emilie D. Dysregulation of IL-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1429–1435
  • Kalechman Y., Gafter U., Da J. P., Albeck M., Alarcon-Segovia D., Sredni B. Delay in the onset of systemic lupus erythematosis following treatment with the immunomodulator AS101. J. Immunol 1997; 159: 2658–2667
  • Eskdale J., Wordsworth P., Bowman S., Field M., Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 1997; 49: 635–639
  • Mehrian R., Quismorio F. P., Strassmann G., Stimmler M. M., Horwitz D. A., Kitridou R. C., Gauderman W. J., Morrison J., Brautbar C., Jacob C. O. Synergistic effect between IL-10, and bcl-2, genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis and Rheum 1998; 41: 596–602
  • Blakemore A. I.F., Tarlow J. K., Cork M. J., Gordon C., Emery P., Duff G. W. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1380–1385
  • Suzuki H., Matsui Y., Kashiwagi H. Interleukin-1 receptor antagonist gene polymorphism in Japanese patients with systemic lupus erythematosus. Arthritis Rheum 1990; 40: 389–390
  • Tjernstrom F., Hellmer G., Nived O., Truedsson L., Sturfelt G. Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17, DQ2) in determining susceptibility to systemic lupus erythematosus. Lupus 1999; 8: 103–108
  • Linker M., IsraeliWallace D. J., Prehn J. L., Nand R., Li L., Klinenberg J. R. A greater varibility in the 3 flanking region of the IL-6 gene in patients with systemic lupus erythematosus (SLE). Autoimmunity 1996; 23: 199–209
  • Kanemitsu S., Takabayashi A., Sasaki Y., Kuromaru R., Ihara K., Kaku Y., Sakai K., Hara T. Association of interleukin-4 receptor and interleukin-4 promoter gene polymorphisms with systemic lupus erythematosus. Arthritis & Rheum 1999; 42: 1298–1300
  • Kono D. H., Theofilopoulos A. N. Genetic contributions to SLE. J. Autoimmunity 1996; 9: 437–452
  • Wu J., Wilson J., He J., Xiang L., Schur P. H., Mountz J. D. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest 1996; 98: 1107–1113
  • Huang Q. R., Morris D., Manolios N. Evaluation of the Bcl-2 gene as a susceptibility locus linked to the clinical expression of systemic lupus erythematosus. Rheumatol. International 1996; 16: 121–124
  • Lorenz H. M., Grunke M., Hieronymous T., Herrmann M., Kuhnel A., Manger B., Kalden J. R. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 1997; 40: 306–317
  • Tsao B. P., Cantor R. M., Kalunian K. C., Chen C. J., Badsha H., Singh R., Wallace D. J., Kitridou R. C., Chen S. L., Shen N., Song Y. W., Isenberg D. A., Yu C. L., Hahn B. H., Rotter J. I. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J. Clin. Invest 1997; 99: 725–731
  • Tsao B. P., Cantor R. M., Grossman J. M., Shen N., Teophilov N. T., Wallace D. J., Arnett F. C., Hartung K., Goldstein R., Kalunian K. C., Hahn B. H., Rotter J. I. PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J. of Clin. Invest 1999; 103: 1135–1140
  • Delrieu O., Michel M., Frances C., Meyer O., Michel C., Wittke F., Crassard I., Bach J. F., Tournier Lasserve E., Piette J. C. Poly (ADP-RIBOSE) polymerase alleles in French Caucasians are associated neither with lupus nor with primary antiphospholipid syndrome. Arthritis & Rheum 1999; 42: 2194–2197
  • Perl A., Colombo E., Dai H., Agarwal R., Mark K. A., Banki K., Poiesz B. J., Phillips P. E., Hoch S. O., Reveille J. D., Arnett F. C. Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes: Correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum 1995; 38: 1660–1671
  • Magistrelli C., Samoilova E., Agarwal R. K., Banki K., Ferrante P., Vladutiu A., Phillips P. E., Perl A. Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity. Immunogenet 1999; 49: 829–834
  • Vyse T. J., Kotzin B. L. Genetic basis of systemic lupus erythematosus. Curr. Opinion Rheumatol 1996; 8: 843–851
  • Mohan C., Yu Y., Morel L., Yang P., Wakeland E. K. Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts t cell activation, differentiation, and cell death. J. Immunol 1999; 162: 6492–6502
  • Mohan C., Morel L., Yang P., Watanabe H., Croker B., Gilkeson G., Wakeland E. K. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J. Clin. Invest 1999; 103: 1685–1695
  • Theofilopoulos A. N., Kono D. H. The genes of systemic autoimmunity. J. Assoc. Amer. Physician 1999; 111: 228–240
  • Becker K. G., Simon R. M., Bailey J. E., WilsonFreidlin B., Biddison W. E., McFarland H. F., Trent J. M. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl. Acad. Sci. USA 1998; 95: 9979–9984
  • Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516–1517
  • Collins F. S. Molecular genetics in clinical practice I: sequencing the human genome. Hospital Prac 1997; 35: 53
  • Moser K. L., Neas B. R., Salmon J. E., Yu H., Gray C., McGuireAsundi N., Bruner G. R., Fox J., Kelly J., Henshall S., Bacino D., Dietz M., Hogue R., Koelsch G., Nightingale L., Shaver T., Abdou N. I., Albert D. A., Carson C., Petri M., Treadwell E. L., James J. A., Harley J. B. Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome Iq in African-American pedigrees. Proc. Natl. Acad. Sci. USA 1998; 95: 14869–14874
  • Gaffney P. M., Kearns G. M., Shark K. B., Ortmann W. A., Selby S. A., Malmgren M. L., Rohlf K. E., Ockenden T. C., Messner R. P., King R. A., Rich S. S., Behrens T. W. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc. Natl. Acad. Sci. USA 1998; 95: 14875–14879
  • Shai R., Quismorio F. P.J., Li L., Kwon O. J., Morrison J., Wallace D. J., Neuwelt C. M., Brautbar C., Gauderman W. J., Jacob C. O. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum. Mol. Genet 1999; 8: 639–644
  • Harley J. B., Moser K. L., Gaffney P. M., Behrens T. W. The genetics of human systemic lupus erythematosus. Curr. Opin. Immunol 1998; 10: 690–696
  • Moulds J. M., Reveille J. D., Arnett F. C. Structural polymorphisms of complement receptor 1 (CR1) in systemic lupus erythematosus (SLE) patients and normal controls of three ethnic groups. Clin. Exp. Immunol 1996; 105: 302–305

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.